International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases

Cancer

Volumn 118, Issue 5, 2012, Pages 1457-1465

  Chow, Edward ^a   Nguyen, Janet ^a   Zhang, Liying ^a   Tseng, Ling Ming ^b   Hou, Ming Feng ^c   Fairchild, Alysa ^d   Vassiliou, Vassilios ^e   Jesus Garcia, Reynaldo ^f   Alm El Din, Mohamed A ^g   Kumar, Aswin ^h   Forges, Fabien ^i,j   Chie, Wei Chu ^k   Bottomley, Andrew ^l  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CROSS CANCER INSTITUTE   (Canada)

^e Bank of Cyprus Group Oncology Centre   (Cyprus)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g TANTA UNIVERSITY HOSPITAL   (Egypt)

^h REGIONAL CANCER CENTRE   (India)

ⁱ UNIVERSITÉ JEAN MONNET   (France)

^j Saint Etienne University Hospital   (France)

^k NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^l EORTC DATA CENTER   (Belgium)

more..

Author keywords

bone metastases; clinical trials; European Organization for Research and Treatment of Cancer (EORTC) QLQ BM22; health related quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAZIL; CANADA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONSTRUCT VALIDITY; CONTROLLED STUDY; CULTURAL FACTOR; CYPRUS; EGYPT; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE BONE METASTASIS; FEMALE; FIELD STUDY; FRANCE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SENSITIVITY ANALYSIS; TAIWAN; TEST RETEST RELIABILITY;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA; FEMALE; GEOGRAPHY; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INTERNATIONALITY; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL;

EID: 84857357339     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26410     Document Type: Article

References (14)

1. Mundy GR,. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002; 2: 584-593. (Pubitemid 37328925)
2. Tubiana-Hulin M,. Incidence, prevalence and distribution of bone metastases. Bone. 1991; 12 (suppl 1): S9-S10.
3. Soni MK, Cella D,. Quality of life and symptom measures in oncology: an overview. Am J Manag Care. 2002; 8 (suppl 18): S560-S573. (Pubitemid 36096928)
4. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-376. (Pubitemid 23073154)
5. Chow E, Hird A, Velikova G, et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer. 2009; 45: 1146-1152.
6. Blazeby J, Sprangers M, Cull A, et al. EORTC Quality of Life Group: Guidelines for Developing Questionnaire Modules. 3rd ed. Revised. Brussels, Belgium: European Organization for Research and Treatment of Cancer; 2002. Available at:. Accessed March 1, 2011
7. Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels, Belgium: European Organization for Research and Treatment of Cancer; 2001.
8. Chow E, Wu JS, Hoskin P, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol. 2002; 64: 275-280. (Pubitemid 35254020)
9. Tabachnick BG, Fidell LS,. Using Multivariate Statistics. 4th ed. London, UK: HarperCollins; 2001.
10. Hays RD, Hayashi T, Carson S, et al. User's Guide for the Multi-Trait Analysis Program (MAP). Santa Monica, CA: Rand Corporation; 1998.
11. Nunnally JC, Bernstein IH,. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
12. Greimel E, Nordin A, Lanceley A, et al. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer. 2011; 47: 183-190.
13. Cocks K, Cohen D, Wisloff F, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007; 43: 1670-1678. (Pubitemid 47042371)
14. Broom R, Du H, Clemons M, et al. Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain. J Pain Symptom Manage. 2009; 38: 244-257.